Homoharringtonine induced immune alteration for an Efficient Anti-tumor Response in Mouse Models of Non-small Cell Lung Adenocarcinoma Expressing Kras Mutation

Homoharringtonine (HHT), an inhibitor of protein synthesis, has been used to treat leukemia. Its therapeutic effects on non-small cell lung adenocarcinoma carrying KRAS mutation and their immune system are less understood. The present study examined the therapeutic efficacy and the immune effects of...

Descripción completa

Detalles Bibliográficos
Autores principales: Weng, Tzu-Yang, Wu, Hsuan Franziska, Li, Chung-Yen, Hung, Yu-Hsuan, Chang, Yu-Wei, Chen, Yi-Ling, Hsu, Hui-Ping, Chen, Yu-Hung, Wang, Chih-Yang, Chang, Jang-Yang, Lai, Ming-Derg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5974086/
https://www.ncbi.nlm.nih.gov/pubmed/29844447
http://dx.doi.org/10.1038/s41598-018-26454-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5974086/
https://www.ncbi.nlm.nih.gov/pubmed/29844447
http://dx.doi.org/10.1038/s41598-018-26454-w

Ejemplares similares